captopril has been researched along with slv 306 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godes, M; Hocher, B; Neumayer, HH; Richter, CM; Simon, K; Thöne-Reinke, C; Thormählen, D | 1 |
1 other study(ies) available for captopril and slv 306
| Article | Year |
|---|---|
Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
Topics: Administration, Oral; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartic Acid Endopeptidases; Benzazepines; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelin-Converting Enzymes; Fibrosis; Kidney; Metalloendopeptidases; Neprilysin; Protease Inhibitors; Proteinuria; Rats; Rats, Wistar; Time Factors | 2004 |